Eczema Sufferers…New Clinical Trial – Seeking Participants

Do you know anyone suffering from eczema? Call Today – 855.554.6374

note: Qualified study participants will receive study drug, related testing, and compensation for their time and travel.

Clinical Trial Government Identifier #NCT03569293

Sponsor: AbbVie





Genders eligible for study: Male/Female Ages eligible for study: 18-75 years old
NEW STUDY, NOW ENROLLING – Moderate to Severe atopic dermatitis (eczema) present for at least 1 year; no prior use of dupilumab allowed August 2018 – May 2022